0
Research Papers

Cellular Uptake and Intracellular Cargo Release From Dextran Based Nanogel Drug Carriers

[+] Author and Article Information
M. Carme Coll Ferrer

Department of Anesthesiology and Critical Care
and Department of Materials Science and Engineering,
University of Pennsylvania,
Philadelphia, PA 19104

Peter Sobolewski

Department of Anesthesiology and Critical Care,
University of Pennsylvania,
Philadelphia, PA 19104

Russell J. Composto

Department of Materials Science and Engineering,
University of Pennsylvania,
Philadelphia, PA 19104

David M. Eckmann

Department of Anesthesiology and Critical Care,
University of Pennsylvania,
Philadelphia,
PA 19104
e-mail: eckmanndm@uphs.upenn.edu

1These authors contributed equally to this work.

2Corresponding author.

Manuscript received September 11, 2012; final manuscript received December 10, 2012; published online July 11, 2013. Assoc. Editor: Malisa Sarntinoranont.

J. Nanotechnol. Eng. Med 4(1), 011002 (Jul 11, 2013) (8 pages) Paper No: NANO-12-1120; doi: 10.1115/1.4023246 History: Received September 11, 2012; Revised December 10, 2012

Nanogels (NG) hold great promise as a drug delivery platform. In this work, we examine the potential of lysozyme-dextran nanogels (LDNG) as drug carriers in vitro using two cell lines: a model target tissue, human umbilical cord vein endothelial cells (HUVEC) and a model of the mononuclear phagocyte system (phorbol 12-myristate 13-acetate (PMA)-stimulated THP-1 cells). The LDNG (∼100 nm) were prepared with rhodamine-label dextran (LRDNG) via Maillard reaction followed by heat-gelation reaction and were loaded with a fluorescent probe, 5-hexadecanoylaminofluorescein (HAF), as a mock drug. Epifluorescence microscopy confirmed rapid uptake of LRDNG by HUVEC. Although LysoTracker Green staining indicated a lysosomal fate for LRDNG, the mock drug cargo (HAF) diffused extensively inside the cell within 15 min. Flow cytometry and confocal microscopy indicated slow uptake of LRDNG in PMA-stimulated THP-1 cells, with only 41% of cells containing LRDNG after 24 h exposure. Finally, 24 h exposure to LRDNG did not affect the viability of either cell type at the dose studied (20 μg/ml). At a higher dose (200 μg/ml), LRDNG resulted in a marked loss of viability of HUVEC and THP-1, measuring 30% and 38%, respectively. Collectively, our results demonstrate the great potential of LRDNG as a drug delivery platform, combining simple production, rapid uptake and cargo release in target cells with “stealth” properties and low cytotoxicity.

FIGURES IN THIS ARTICLE
<>
Copyright © 2013 by ASME
Your Session has timed out. Please sign back in to continue.

References

Oh, J. K., Drumright, R., Siegwart, D. J., and Matyjaszewski, K., 2008, “The Development of Microgels/Nanogels for Drug Delivery Applications,” Prog. Polym. Sci., 33(4), pp. 448–477. [CrossRef]
Raemdonck, K., Demeester, J., and De Smedt, S., 2009, “Advanced Nanogel Engineering for Drug Delivery,” Soft Matter, 5(4), pp. 707–715. [CrossRef]
Kuckling, D., Vo, C. D., and Wohlrab, S. E., 2002, “Preparation of Nanogels With Temperature-Responsive Core and pH-Responsive Arms by Photo-Cross-Linking,” Langmuir, 18(11), pp. 4263–4269. [CrossRef]
Li, X., Zuo, J., Guo, Y. L., and Yuan, X. H., 2004, “Preparation and Characterization of Narrowly Distributed Nanogels With Temperature-Responsive Core and pH-Responsive Shell,” Macromolecules, 37(26), pp. 10042–10046. [CrossRef]
Lemarchand, C., Gref, R., and Couvreur, P., 2004, “Polysaccharide-Decorated Nanoparticles,” Eur. J. Pharm. Biopharm., 58(2), pp. 327–341. [CrossRef] [PubMed]
Mitra, S., Gaur, U., Ghosh, P. C., and Maitra, A. N., 2001, “Tumour Targeted Delivery of Encapsulated Dextran-Doxorubicin Conjugate Using Chitosan Nanoparticles as Carrier,” J. Controlled Release, 74(1–3), pp. 317–323. [CrossRef]
Li, J., Yu, S. Y., Yao, P., and Jiang, M., 2008, “Lysozyme-Dextran Core-Shell Nanogels Prepared Via a Green Process,” Langmuir, 24(7), pp. 3486–3492. [CrossRef] [PubMed]
Nagahama, K., Ouchi, T., and Ohya, Y., 2008, “Biodegradable Nanogels Prepared by Self-Assembly of Poly(L-Lactide)-Grafted Dextran: Entrapment and Release of Proteins,” Macromol. Biosci., 8(11), pp. 1044–1052. [CrossRef] [PubMed]
Li, J., and Yao, P., 2009, “Self-Assembly of Ibuprofen and Bovine Serum Albumin-Dextran Conjugates Leading to Effective Loading of the Drug,” Langmuir, 25(11), pp. 6385–6391. [CrossRef] [PubMed]
Jeong, Y. I., Choi, K. C., and Song, C. E., 2006, “Doxorubicin Release From Core-Shell Type Nanoparticles of Poly(Dl-Lactide-Co-Glycolide)-Grafted Dextran,” Arch. Pharmacal Res., 29(8), pp. 712–719. [CrossRef]
Pan, X. Y., Yao, P., and Jiang, M., 2007, “Simultaneous Nanoparticle Formation and Encapsulation Driven by Hydrophobic Interaction of Casein-Graft-Dextran and Beta-Carotene,” J. Colloid Interface Sci., 315(2), pp. 456–463. [CrossRef] [PubMed]
Jung, S. W., Jeong, Y. I., Kim, Y. H., Choi, K. C., and Kim, S. H., 2005, “Drug Release From Core-Shell Type Nanoparticles of Poly(Dl-Lactide-Co-Glycolide)-Grafted Dextran,” J. Microencapsul., 22(8), pp. 901–911. [CrossRef] [PubMed]
Lemarchand, C., Gref, R., Passirani, C., Garcion, E., Petri, B., Muller, R., Costantini, D., and Couvreur, P., 2006, “Influence of Polysaccharide Coating on the Interactions of Nanoparticles With Biological Systems,” Biomaterials, 27(1), pp. 108–118. [CrossRef] [PubMed]
Stutman, D. R., Klein, A., Elaasser, M. S., and Vanderhoff, J. W., 1985, “Mechanism of Core Shell Emulsion Polymerization,” Ind. Eng. Chem. Prod. Res. Dev., 24(3), pp. 404–412. [CrossRef]
Blackburn, W. H., and Lyon, L. A., 2008, “Size-Controlled Synthesis of Monodisperse Core/Shell Nanogels,” Colloid Polym. Sci., 286(5), pp. 563–569. [CrossRef] [PubMed]
Jin, Q., Liu, X., Liu, G., and Ji, J., 2010, “Fabrication of Core or Shell Reversibly Photo Cross-Linked Micelles and Nanogels From Double Responsive Water-Soluble Block Copolymers,” Polymer, 51(6), pp. 1311–1319. [CrossRef]
Qi, J. N., Yao, P., He, F., Yu, C. L., and Huang, C. O., 2010, “Nanoparticles With Dextran/Chitosan Shell and BSA/Chitosan Core-Doxorubicin Loading and Delivery,” Int. J. Pharm., 393(1–2), pp. 176–184. [CrossRef] [PubMed]
Deng, W., Li, J., Yao, P., He, F., and Huang, C., 2010, “Green Preparation Process, Characterization and Antitumor Effects of Doxorubicin-BSA-Dextran Nanoparticles,” Macromol. Biosci., 10(10), pp. 1224–1234. [CrossRef] [PubMed]
Lee, H.-S., Stachelek, S. J., Tomczyk, N., Finley, M. J., Composto, R. J., and Eckmann, D. M., 2013, “Correlating Macrophage Morphology and Cytokine Production Resulting From Biomaterial Contact,” J. Biomed. Mater. Res. Part A, 101A(1), pp. 203–212. [CrossRef]
Coll Ferrer, M. C., Ferrier, R. C., Jr., Eckmann, D. M., and Composto, R. J., “A Facile Route to Synthesize Nanogels Doped With Silver Nanoparticles,” J. Nanopart. Res., (in press). [CrossRef]
Costes, S. V., Daelemans, D., Cho, E. H., Dobbin, Z., Pavlakis, G., and Lockett, S., 2004, “Automatic and Quantitative Measurement of Protein-Protein Colocalization in Live Cells,” Biophys. J., 86(6), pp. 3993–4003. [CrossRef] [PubMed]
Shi, J., Votruba, A. R., Farokhzad, O. C., and Langer, R., 2010, “Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications,” Nano Lett., 10(9), pp. 3223–3230. [CrossRef] [PubMed]
Oakenfull, D., Pearce, J., and Burley, R., 1997, Food Proteins and Their Applications, Vol. 80, Marcel Dekker, New York, pp. 111–142.
Ibrahim, H. R., Higashiguchi, S., Juneja, L. R., Kim, M., and Yamamoto, T., 1996, “A Structural Phase of Heat-Denatured Lysozyme With Novel Antimicrobial Action,” J. Agric. Food Chem., 44(6), pp. 1416–1423. [CrossRef]
Coll Ferrer, M. C., Yang, S., Eckmann, D. M., and Composto, R. J., 2010, “Creating Biomimetic Polymeric Surfaces by Photochemical Attachment and Patterning of Dextran,” Langmuir, 26(17), pp. 14126–14134. [CrossRef] [PubMed]
Ombelli, M., Composto, R. J., Meng, Q. C., and Eckmann, D. M., 2005, “A Quantitative and Selective Chromatography Method for Determining Coverages of Multiple Proteins on Surfaces,” J. Chromatogr., B-Anal. Technol. Biomed. Life Sci., 826(1–2), pp. 198–205. [CrossRef]
Frazier, R. A., Matthijs, G., Davies, M. C., Roberts, C. J., Schacht, E., and Tendler, S. J. B., 2000, “Characterization of Protein-Resistant Dextran Monolayers,” Biomaterials, 21(9), pp. 957–966. [CrossRef] [PubMed]
Martwiset, S., Koh, A. E., and Chen, W., 2006, “Nonfouling Characteristics of Dextran-Containing Surfaces,” Langmuir, 22(19), pp. 8192–8196. [CrossRef] [PubMed]
Piehler, J., Brecht, A., Hehl, K., and Gauglitz, G., 1999, “Protein Interactions in Covalently Attached Dextran Layers,” Colloids Surf., B, 13(6), pp. 325–336. [CrossRef]
Passirani, C., Barratt, G., Devissaguet, J. P., and Labarre, D., 1998, “Interactions of Nanoparticles Bearing Heparin or Dextran Covalently Bound to Poly(Methyl Methacrylate) With the Complement System,” Life Sci., 62(8), pp. 775–785. [CrossRef] [PubMed]
Cansell, M., Parisel, C., Jozefonvicz, J., and Letourneur, D., 1999, “Liposomes Coated With Chemically Modified Dextran Interact With Human Endothelial Cells,” J. Biomed. Mater. Res., 44(2), pp. 140–148. [CrossRef] [PubMed]
Letourneur, D., Parisel, C., Prigent-Richard, S., and Cansell, M., 2000, “Interactions of Functionalized Dextran-Coated Liposomes With Vascular Smooth Muscle Cells,” J. Controlled Release, 65(1–2), pp. 83–91. [CrossRef]
Ning, S., Huang, Q., Li, J., Zhang, Y., and Liu, Y.-N., 2011, “Functionalized Dextran-Coated Liposomes for Doxorubicin Loading,” J. Controlled Release, 152, pp. E49–E51. [CrossRef]
Du, Y.-Z., Weng, Q., Yuan, H., and Hu, F.-Q., 2011, “Synthesis and Antitumor Activity of Stearate-G-Dextran Micelles for Intracellular Doxorubicin Delivery,” ACS Nano, 4(11), pp. 6894–6902. [CrossRef]
Sun, H., Guo, B., Li, X., Cheng, R., Meng, F., Liu, H., and Zhong, Z., 2011, “Shell-Sheddable Micelles Based on Dextran-Ss-Poly(Epsilon-Caprolactone) Diblock Copolymer for Efficient Intracellular Release of Doxorubicin,” Biomacromolecules, 11(4), pp. 848–854. [CrossRef]
Choi, K.-C., Bang, J.-Y., Kim, P.-I., Kim, C., and Song, C.-E., 2008, “Amphotericin B-Incorporated Polymeric Micelles Composed of Poly(D,L-Lactide-Co-Glycolide)/Dextran Graft Copolymer,” Int. J. Pharm., 355(1–2), pp. 224–230. [CrossRef] [PubMed]
Van Thienen, T. G., Raemdonck, K., Demeester, J., and De Smedt, S. C., 2007, “Protein Release From Biodegradable Dextran Nanogels,” Langmuir, 23(19), pp. 9794–9801. [CrossRef] [PubMed]
Patnaik, S., Sharma, A. K., Garg, B. S., Gandhi, R. P., and Gupta, K. C., 2007, “Photoregulation of Drug Release in Azo-Dextran Nanogels,” Int. J. Pharm., 342(1–2), pp. 184–193. [CrossRef] [PubMed]
Genz, A. K.,Engelhardt, W., and Busche, R., 1999, “Maintenance and Regulation of the pH Microclimate at the Luminal Surface of the Distal Colon of Guinea-Pig,” J. Physiol., 517(2), pp. 507–519. [CrossRef] [PubMed]
Tournier, J. F., Lopez, A., and Tocanne, J. F., 1989, “Effect of Cell Substratum on Lateral Mobility of Lipids in the Plasma-Membrane of Vascular Endothelial Cells,” Exp. Cell Res., 181(1), pp. 105–115. [CrossRef] [PubMed]
Nachman, R. L., and Jaffe, E. A., 2004, “Endothelial Cell Culture: Beginnings of Modern Vascular Biology,” J. Clin. Invest., 114(8), pp. 1037–1040. [CrossRef] [PubMed]
Dobrovolskaia, M. A., Aggarwal, P., Hall, J. B., and McNeil, S. E., 2008, “Preclinical Studies to Understand Nanoparticle Interaction With the Immune System and Its Potential Effects on Nanoparticle Biodistribution,” Mol. Pharm., 5(4), pp. 487–495. [CrossRef] [PubMed]
Tsuchiya, S., Kobayashi, Y., Goto, Y., Okumura, H., Nakae, S., Konno, T., and Tada, K., 1982, “Induction of Maturation in Cultured Human Monocytic Leukemia-Cells by a Phorbol Diester,” Cancer Res., 42(4), pp. 1530–1536. [PubMed]
Sahay, G., Alakhova, D. Y., and Kabanov, A. V., “Endocytosis of Nanomedicines,” J. Controlled Release, 145(3), pp. 182–195. [CrossRef]
Massia, S. P., and Stark, J., 2001, “Immobilized RGD Peptides on Surface-Grafted Dextran Promote Biospecific Cell Attachment,” J. Biomed. Mater. Res., 56(3), pp. 390–399. [CrossRef] [PubMed]

Figures

Grahic Jump Location
Fig. 1

Characterization of LRDNG. (a) Size distribution as measured by DLS following synthesis (line) and after 6 month storage at 4  °C (open circles). (b) TEM micrographs showing particles after drying on holy carbon grid. The scale bars correspond to 0.5 μm and 50 nm (inset). (c) Histogram of particle size distribution as measured from TEM micrographs. The hydrodynamic diameter (DH) of the LRDNG is 107 ± 26 nm whereas the average particle size in the dried state (d) is 57 ± 13 nm.

Grahic Jump Location
Fig. 2

Viability of cells after 24 h exposure to a range of LRDNG concentrations. (a) Viability of HUVEC, determined using alamarBlue® indicator. (b) Viability of PMA-stimulated, GFP-actin THP-1 cells, determined using Calcein Violet. * indicates significant difference from control, p < 0.05.

Grahic Jump Location
Fig. 3

Summary of loading amount, defined as the weight ratio of loaded HAF to LRDNG ([HAF]/[LRDNG]) and loading efficiency, defined as the weight ratio of loaded HAF to initial HAF ([HAF]/[HAF]0) as a function of the loading concentration

Grahic Jump Location
Fig. 4

HUVEC uptake of HAF-LRDNG by epifluorescence microscopy. (a) Representative epifluorescence photomicrograph of cells after 1 h incubation with LRDNG (red) loaded with mock drug, HAF, (green), namely HAF-LRDNG. The scale bar corresponds to 10 μm. (b) Uptake of HAF-LRDNG and (c) intracellular (closed circles) and extracellular (open circles) release of mock drug HAF as a function of incubation time.

Grahic Jump Location
Fig. 5

HUVEC uptake of HAF-LRDNG and intracellular HAF release after 15 min by epifluorescence microscopy. Representative epifluorescence photomicrograph of cells after 15 min incubation with LRDNG (red) loaded with mock drug, HAF, (green), namely HAF-LRDNG. The scale bar corresponds to 20 μm.

Grahic Jump Location
Fig. 6

Localization of LRDNG (red) inside HUVEC after 1 h. RDNG are pseudocolored red, lysozymes are pseudocolored green, and colocalization, as determined by the Costes image analysis, is highlighted in white. (a) Single, middle confocal slice of a representative cell. (b) Zoomed in view of the region highlighted in panel A. (c) XZ rendering for the plane indicated by the yellow line in panel B.

Grahic Jump Location
Fig. 7

Uptake of LRDNG by PMA-stimulated, GFP-actin THP-1 cells by confocal microscopy following 24 h incubation. (a) Representative epifluorescence photomicrograph of middle slice of confocal z stacks (b) 3D image of a single cell. (c) Sum of fluorescence intensities of green (GFP-actin) and red (LRDNG) channels for all z heights (0.2 μm steps) of the 3D image, indicating LRDNG inside the cell body and not on the surface.

Grahic Jump Location
Fig. 8

Flow cytometry analysis of LRDNG uptake by PMA-stimulated, GFP-actin THP-1 cells. Histograms of (a) control cells and cells incubated with LRDNG for (b) 1 h, (c) 3 h, (d) 6 h, and (e) 24 h. (f) Summary of percentage of cells containing LRDNG as a function of incubation time.

Tables

Errata

Discussions

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging and repositioning the boxes below.

Related Journal Articles
Related eBook Content
Topic Collections

Sorry! You do not have access to this content. For assistance or to subscribe, please contact us:

  • TELEPHONE: 1-800-843-2763 (Toll-free in the USA)
  • EMAIL: asmedigitalcollection@asme.org
Sign In